BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2268107)

  • 1. The pathology of nonpalpable breast cancer.
    Kopald KH; Hiatt JR; Irving C; Giuliano AE
    Am Surg; 1990 Dec; 56(12):782-7. PubMed ID: 2268107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy of the breast for mammographically detected lesions.
    Franceschi D; Crowe J; Zollinger R; Duchesneau R; Shenk R; Stefanek G; Shuck JM
    Surg Gynecol Obstet; 1990 Dec; 171(6):449-55. PubMed ID: 2244276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in patients with nonpalpable breast carcinomas.
    Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
    Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open breast biopsy. A critical analysis.
    Shroff JH; Lloyd LR; Schroder DM
    Am Surg; 1991 Aug; 57(8):481-5. PubMed ID: 1928989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpalpable invasive breast cancer.
    Wilhelm MC; Edge SB; Cole DD; deParedes E; Frierson HF
    Ann Surg; 1991 Jun; 213(6):600-3; discussion 603-5. PubMed ID: 2039291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in nonpalpable lesions: can mammographic parenchymal pattern improve the predictive value of biopsy?
    Weaver M
    Am Surg; 1992 Nov; 58(11):692-4. PubMed ID: 1485702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging and treatment of clinically occult breast cancer.
    Schwartz GF; Feig SA; Rosenberg AL; Patchefsky AS; Schwartz AB
    Cancer; 1984 Mar; 53(6):1379-84. PubMed ID: 6692326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle localization for nonpalpable breast lesions.
    Sailors DM; Crabtree JD; Land RL; Rose WB; Burns RP; Barker DE
    Am Surg; 1994 Mar; 60(3):186-9. PubMed ID: 8116978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of needle localization mammographically assisted biopsy of the breast.
    Senofsky GM; Davies RJ; Olson L; Skully P; Olshen R
    Surg Gynecol Obstet; 1990 Nov; 171(5):361-5. PubMed ID: 2237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiologic recommendation for breast biopsy on screening mammography reports.
    Geelhoed GW; Barr HM; Curtis DJ; Olmsted WW
    Am Surg; 1991 Jul; 57(7):419-24. PubMed ID: 2058848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of roentgenologic characteristics and risk factors for nonpalpable carcinoma of the breast.
    Harkins K; Tartter PI; Hermann G; Squitieri R; Brower ST; Keller RJ
    J Am Coll Surg; 1994 Feb; 178(2):149-54. PubMed ID: 8173725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the results of mammographically guided biopsies of the breast.
    McCreery BR; Frankl G; Frost DB
    Surg Gynecol Obstet; 1991 Mar; 172(3):223-6. PubMed ID: 1847244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a multidisciplinary breast center. Analysis of disease discovered.
    Silverstein MJ; Gamagami P; Masetti R; Legmann MD; Craig PH; Gierson ED
    Surg Oncol Clin N Am; 1997 Apr; 6(2):301-14. PubMed ID: 9115497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.